A Study of Advanced or Metastatic Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the efficacy and safety of LY2603618 in
combination with pemetrexed and any side effects that might be associated with it along with
determining the effects of LY2603618 in combination with pemetrexed in participants with
advanced or metastatic Non-small Cell Lung Cancer (NSCLC).